All comments can be sent at [email protected] Deadline of submission of comments shall be by 08 January 2021.
Attachment:->Draft for Comments – Supplement to FDA Circular No.2014-016 Implementing Guidelines AO2013-0022 on the Renewal of cGMP Clearance
FDA Advisory || FDA STATEMENT ON THE ISSUE OF RECALLED…
NP-SVP(A)-2022-008-CTQAL || Calibration, Preventive Maintenance and Repair of Laboratory Equipment…
Announcement || Dissemination of the Updates and Amendments to the…
Announcement || LICENSING SEMINAR FOR HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES (HUHS) ESTABLISHMENTS…
Civic Drive Filinvest Corporate City
(02) 8857-1900local 1000(02) 8842-5635
Copyright © 2022. All Rights Reserved.